UTime Ltd
No SEC Form 4 filings for $FXHO in the last 30 days.
See all $FXHO insider activity →Alignment Healthcare (ALHC) shares dropped 24.2% to $6.60 in pre-market trading after its largest California contract was downgraded to 3.5 stars, making it ineligible for bonus payments. Several other stocks also fell, including Entera Bio (ENTX), AT&T (T), Verizon (VZ), and RenX Enterprises (RENX).
UTime Limited (NASDAQ:WTO) shares fell 1% on Thursday, trading between $1.00 and $1.02 versus a prior close of $1.03. Midday volume was 19,345 shares, down 99% from the average. The company reported $0.01 EPS and $6.99 million revenue for the quarter ended March 18.
UTime Ltd (NASDAQ:UTME) announced it will hold an extraordinary general meeting for shareholders on January 26, 2026, at 10:00 AM EST. Both Class A and Class B ordinary shareholders are invited to the meeting. The specific agenda items were not disclosed in the SEC filing.
Over the past 7 days, AlphAI's AI scored 1 news story mentioning FXHO (UTime Ltd). Coverage has skewed bearish: 0 bullish, 0 neutral, and 1 bearish.
Recent FXHO coverage spans financial news and market movers.
Minor pre‑market decline.
UTime Limited (NASDAQ:WTO) shares fell 1% on Thursday, trading between $1.00 and $1.02 versus a prior close of $1.03. Midday volume was 19,345 shares, down 99% from the average. The company reported $0.01 EPS and $6.99 million revenue for the quarter ended March 18.
UTime Ltd (NASDAQ:UTME) announced it will hold an extraordinary general meeting for shareholders on January 26, 2026, at 10:00 AM EST. Both Class A and Class B ordinary shareholders are invited to the meeting. The specific agenda items were not disclosed in the SEC filing.
UTime Ltd has announced an extraordinary general meeting for shareholders on January 26, 2026, at 10:00 AM EST. The meeting will include holders of both Class A and Class B ordinary shares. The specific agenda items for the meeting have not been disclosed yet.
UTime Limited (NASDAQ:WTO) saw its stock surge by 31.7% after announcing a nearly $10 million procurement agreement with Tumu Vertex LLC for smart health devices. This deal involves an initial order of 50,000 premium smart health devices, including blood pressure watches and smart rings, with the first batch set for delivery in Q1 2026. UTime views this as a significant strategic breakthrough in the North American market, aiming to accelerate the development of next-generation health monitoring technologies.
AlphAI scores every news story that mentions FXHO with an AI model for sentiment and relevance, and aggregates insider trades from UTime Ltd's SEC EDGAR Form 4 filings. Figures refresh continuously.
Alignment Healthcare (ALHC) shares dropped 24.2% to $6.60 in pre-market trading after its largest California contract was downgraded to 3.5 stars, making it ineligible for bonus payments. Several other stocks also fell, including Entera Bio (ENTX), AT&T (T), Verizon (VZ), and RenX Enterprises (RENX).
2 min readUTime Limited (NASDAQ:WTO) shares fell 1% on Thursday, trading between $1.00 and $1.02 versus a prior close of $1.03. Midday volume was 19,345 shares, down 99% from the average. The company reported $0.01 EPS and $6.99 million revenue for the quarter ended March 18.
2 min readUTime Ltd (NASDAQ:UTME) announced it will hold an extraordinary general meeting for shareholders on January 26, 2026, at 10:00 AM EST. Both Class A and Class B ordinary shareholders are invited to the meeting. The specific agenda items were not disclosed in the SEC filing.
2 min readUTime Ltd has announced an extraordinary general meeting for shareholders on January 26, 2026, at 10:00 AM EST. The meeting will include holders of both Class A and Class B ordinary shares. The specific agenda items for the meeting have not been disclosed yet.
2 min readUTime Limited (NASDAQ:WTO) saw its stock surge by 31.7% after announcing a nearly $10 million procurement agreement with Tumu Vertex LLC for smart health devices. This deal involves an initial order of 50,000 premium smart health devices, including blood pressure watches and smart rings, with the first batch set for delivery in Q1 2026. UTime views this as a significant strategic breakthrough in the North American market, aiming to accelerate the development of next-generation health monitoring technologies.
3 min readUTime Limited announced a nearly $10 million procurement agreement with Tumu Vertex LLC for 50,000 smart health devices, including blood pressure watches and smart rings. This deal signifies UTime's expansion into the North American medical-grade wearable market, despite the company's current struggles with weak gross profit margins. Deliveries are scheduled to begin in the first quarter of 2026.
3 min readSHENZHEN, China, Nov. 05, 2025 ( GLOBE NEWSWIRE ) -- UTime Limited ( Nasdaq: WTO ) today announced that it is actively promoting its smart wearable devices to more international markets through its existing global distribution channels and partner network.
3 min readSHENZHEN, China, Nov. 03, 2025 ( GLOBE NEWSWIRE ) -- UTime Limited ( Nasdaq: WTO ) today outlined its ongoing exploration in the field of health data analysis, particularly the potential application of artificial intelligence ( AI ) technologies.
3 min readSHENZHEN, China, Oct. 30, 2025 ( GLOBE NEWSWIRE ) -- UTime Limited ( Nasdaq: WTO ) today released its smart ring product. Utilizing the advantage of unnoticeable wear, the product aims to provide users with nighttime and long-term continuous health data monitoring.
3 min readSHENZHEN, China, Oct. 28, 2025 ( GLOBE NEWSWIRE ) -- UTime Limited ( Nasdaq: WTO ) , a global technology company engaged in the design and development of mobile devices, today announced the launch of a smartwatch with integrated blood pressure monitoring functionality, further expanding its ...
3 min read
